FMR CORP 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-11 09:01 am Sale |
2022-04-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 579,788 9.298% |
-353,492 (-37.88%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 933,280 14.999% |
242,046 (+35.02%) |
Filing |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 691,234 14.999% |
50,543 (+7.89%) |
Filing |